Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald M Witteles

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
Cardiovascular Drugs and Therapy|April 9, 2009
Nesiritide, heart failure, and renal dysfunction: irrational exuberance or throwing the baby out with the bathwater. Editorial to: "Impact of nesiritide on renal function and mortality in patients suffering from heart failure" by Dontas et alRonald M Witteles
Journal of Cardiac Failure|February 7, 2019
Doxycycline and Ursodiol for ATTR Amyloidosis: Not Ready for Prime TimeRonald M Witteles
JACC. Cardiooncology|June 17, 2026
The Promise and Pitfalls of TTR Stabilization Assays in ATTR-CMRonald M Witteles
Journal of Cardiac Failure|April 4, 2016
Biomarkers as Predictors of Cardiac Toxicity From Targeted Cancer TherapiesRonald M Witteles
JACC. Cardiooncology|November 3, 2021
Cardiac Transplantation and Mechanical Circulatory Support in AmyloidosisRonald M Witteles
Journal of the American College of Cardiology|January 22, 2011
Radiation therapy for breast cancer: buyer bewareRonald M Witteles
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2012
Underestimating cardiac toxicity in cancer trials: lessons learned?Ronald M Witteles, Melinda Telli
Circulation|April 13, 2016
Response to Letter Regarding Article, "Myocardial Protection During Cardiotoxic Chemotherapy"Ronald M Witteles, Xavier Bosch
Circulation|November 11, 2015
Myocardial Protection During Cardiotoxic ChemotherapyRonald M Witteles, Xavier Bosch
JAMA Internal Medicine|September 27, 2016
Accreditation Council for Graduate Medical Education (ACGME) Milestones-Time for a Revolt?Ronald M Witteles, Abraham Verghese
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Cardiovascular Drugs and Therapy|April 9, 2009
Nesiritide, heart failure, and renal dysfunction: irrational exuberance or throwing the baby out with the bathwater. Editorial to: "Impact of nesiritide on renal function and mortality in patients suffering from heart failure" by Dontas et alRonald M Witteles
Journal of Cardiac Failure|February 7, 2019
Doxycycline and Ursodiol for ATTR Amyloidosis: Not Ready for Prime TimeRonald M Witteles
JACC. Cardiooncology|June 17, 2026
The Promise and Pitfalls of TTR Stabilization Assays in ATTR-CMRonald M Witteles
Journal of Cardiac Failure|April 4, 2016
Biomarkers as Predictors of Cardiac Toxicity From Targeted Cancer TherapiesRonald M Witteles
JACC. Cardiooncology|November 3, 2021
Cardiac Transplantation and Mechanical Circulatory Support in AmyloidosisRonald M Witteles
Journal of the American College of Cardiology|January 22, 2011
Radiation therapy for breast cancer: buyer bewareRonald M Witteles
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2012
Underestimating cardiac toxicity in cancer trials: lessons learned?Ronald M Witteles, Melinda Telli
Circulation|April 13, 2016
Response to Letter Regarding Article, "Myocardial Protection During Cardiotoxic Chemotherapy"Ronald M Witteles, Xavier Bosch
Circulation|November 11, 2015
Myocardial Protection During Cardiotoxic ChemotherapyRonald M Witteles, Xavier Bosch
JAMA Internal Medicine|September 27, 2016
Accreditation Council for Graduate Medical Education (ACGME) Milestones-Time for a Revolt?Ronald M Witteles, Abraham Verghese
Pageof 10